Preview

Russian Journal of Cardiology

Advanced search

PREVENTIVE ANTIARRYTHMIC PHARMACOTHERAPY OF FREQUENT ATRIAL FIBRILLATION PAROXYSMS AND SOME SUPRAVENTRICULAR TACHYCARDIA VARIANTS WITH PROPAFENONE AGAINST PLACEBO

About the Authors

Yu. A. Bunin
РМАПО, Москва
Russian Federation


O. N. Denisov
Ульяновская областная клиническая больница, Ульяновск
Russian Federation


L. F. Fedyakina
Ульяновская областная клиническая больница, Ульяновск
Russian Federation


References

1. Бунин Ю.А. Лечение тахиаритмий сердца. М.: Прогресс- Традиция, 2003. – Гл.1. – С.14-31.

2. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: executive summary // Circulation 2001; 104: 2118- 2150.

3. Kastor J.A. Arrhythmias. Philadelphia: W.B.Saunders company.1994, p.25-124.

4. Wolf PA, Kannel WB. Atrial fibrillation as an independent risk faktor for stroke: the Framingham Study//Stroke 1991;22:983-8.

5. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)//Am.J.Cardiol 1994; 74:236-41.

6. Бунин Ю.А. Лечение тахиаритмий сердца// Практическая кардиология. Москва. 2003г., с 9.

7. Bialy D, Lehmann MN, Schumacher DN, Steinman RT, Meissmer MD. Hospitalisation for arrhythmias in the United States: Importance of atrial fibrillation (Abstr)// J Am Coll Cardiol 1992; 19: 41A

8. АCC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: executive summary // Europ.Heart. J. 2006; 27: 1979-2030

9. Zipes DP. Atrial fibrillation. A tachycardia induced cardiomyopathy// Circulation 1997; 95: 562-4.

10. Kannel WB, Abbott RD, Savage DD et al. Coronary heart disease and atrial fibrillation: the Framingham Study// Am Heart J 1983; 106: 389-96.

11. Krahn AD, Manfreda J, Tate RB et al. The natural history of atrial fibrillation: incidence, risk faktors, and prognosis in the Manitoba Follow-up Study// Am J Med 1995; 98: 476-84.

12. Wijfells MCEF, Kirchof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A studi in awake chronically instrumented goats //Circulation 1992: 1954-68.

13. Orejarena L.A., Vidaillet H.J., De Stefano F. et al. Paroxysmal supraventricular tachycardia in the general population// J.Am.Coll. Cardiol.1998; 31:150-157

14. Бунин Ю.А. Фармакотерапия наджелудочковых тахикардий// Российский кардиологический журнал; №3(77); 2009: 1-9

15. Saoudi N., Cosio F., Waldo A. et al. A classification on atrial flutter and regular atrial tachycardia according to electrophy siological mechanisms and anatomical bases// Europ. Heart J. 2001; 22(14): 1162-1182.

16. Chen S.A., Chiang C.E., Yang C.J. et al Sustained atrial tachycardia in adult patients// Circulation,1994; 90: 1262-1278.

17. Berns E., Rinkenberger R.L., Jeang M.K. et al. Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation// Am. J. Cardiol. 1987; 59: 1337-1341.

18. Lucet V., Do N.D., Fidelle J. Anti-arrythmia efficacy of propafenone in children// Arch. Mal. Coeur Vasis. 1987; 80: 1385-1393.

19. Colloridi V., Perri C., Ventriglia F. et al. Oral sotalol in pediatric atrial ectopic tachycardia// Am. Heart J. 1992; 123: 254-256.

20. Guccioni P., Paul T., Garson A. Long-term follow-up of amiodarone therapy in the young// J. Am. Coll. Cardiol. 1990; 15: 1118-1124.

21. Roberts-Thomson K.S., Kistler P.M., Kalman J.M. Atrial tachycardia: mechanisms, diagnosis and management// Curr. Probl. Cardiol. 2005; 30: 529-573.

22. Чреспищеводная электрическая стимуляция сердца/ Под ред. Сулимова В.А., Маколкина В.И. Медицина. Москва, 2001., с 144-159, 177-198.

23. ACC/AHA/ESC Guidelines for the management of patients with supraventricular arrythmias – executive summary // Eur. Heart J. 2003; 24: 1857-1897.

24. Garcia-Civera R., Sanjuan R., Morell S et al. Effect of propafenone on induction and maintenance of atrioventricular nodal reentrant tachycardia// PACE. 1984; 7: 649.

25. Ferguson J.D., Di Marco J.P. Contemporary management of supraventricular tachycardia// Circulation. 2003; 107: 1096-1099.

26. Olgin E.J., Zipes D.P. Specific arrythmias: diagnosis and treatment. / In Braunwald E., Zipes D., Libby P., Bonow R. (eds). Heart disease/ Saunders Company. 2005; p 803-863.

27. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures// JACC, 1995; 26: 555-573.

28. Федякина Л.Ф. Комбинированная профилактическая фармакотерапия пароксизмальной фибрилляции и трепетания предсердий. Автореф. дис. …кандидата мед. наук: 14.00.06. – Москва, 2008.

29. Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. / О.Ю.Реброва. – М.: Медиа Сфера. – 2003.


Review

For citations:


Bunin Yu.A., Denisov O.N., Fedyakina L.F. PREVENTIVE ANTIARRYTHMIC PHARMACOTHERAPY OF FREQUENT ATRIAL FIBRILLATION PAROXYSMS AND SOME SUPRAVENTRICULAR TACHYCARDIA VARIANTS WITH PROPAFENONE AGAINST PLACEBO. Russian Journal of Cardiology. 2010;(5):77-82. (In Russ.)

Views: 314


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)